Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
No abstract
Saved in:
Main Author: | Abdorreza Naser Moghadasi (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
by: Francisco Alejandro Rodriguez-Leal, et al.
Published: (2019) -
Multiple sclerosis in parsis: a historical issue.
by: Abdorreza Naser Moghadasi
Published: (2014) -
Development, and evaluation of drug monitoring system for multiple sclerosis patients
by: Reza Safdari, et al.
Published: (2021) -
Beyond the division of multiple sclerosis into different subgroups: The Concept of Connectomopathy
by: Abdorreza Naser Moghadasi, et al.
Published: (2024) -
De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: the initial Iranian experience
by: Sepideh Paybast, et al.
Published: (2025)